Published in Clin Infect Dis on June 03, 2003
Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PLoS One (2010) 3.67
High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health (2009) 2.13
Durations and Delays in Care Seeking, Diagnosis and Treatment Initiation in Uncomplicated Pulmonary Tuberculosis Patients in Mumbai, India. PLoS One (2016) 1.46
Drug resistance mutations and heteroresistance detected using the GenoType MTBDRplus assay and their implication for treatment outcomes in patients from Mumbai, India. BMC Infect Dis (2012) 1.32
Alarming levels of drug-resistant tuberculosis in HIV-infected patients in metropolitan Mumbai, India. PLoS One (2014) 1.07
Observations on categorisation of new TB cases: implications for controlling drug resistance. Int J Tuberc Lung Dis (2007) 0.98
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay. Tuberculosis (Edinb) (2014) 0.98
Strains of Mycobacterium tuberculosis from western Maharashtra, India, exhibit a high degree of diversity and strain-specific associations with drug resistance, cavitary disease, and treatment failure. J Clin Microbiol (2010) 0.97
Pediatric tuberculosis in young children in India: a prospective study. Biomed Res Int (2013) 0.97
Drug-resistant tuberculosis in Mumbai, India: An agenda for operations research. Oper Res Health Care (2012) 0.90
A world of cities and the end of TB. Trans R Soc Trop Med Hyg (2016) 0.82
Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis. PLoS One (2016) 0.80
Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India. Indian J Public Health (2011) 0.79
Rifampin resistance and diabetes mellitus in a cross-sectional study of adult patients in rural South India. BMC Infect Dis (2015) 0.75
Management of tuberculosis: From drug treatment to control program. Lung India (2011) 0.75
Prevalence of Multidrug Resistant Pulmonary Tuberculosis in North Bihar. J Clin Diagn Res (2015) 0.75
Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai. Lung India (2016) 0.75
First-line anti-tubercular drug resistance of mycobacterial strains from re-treatment cases that were smear-positive at 4(th) month onwards under the Revised National Tuberculosis Control Program. Lung India (2015) 0.75
Antimicrobial resistance: a cause for global concern. BMC Proc (2013) 0.75
Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med (2010) 32.89
Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet (2003) 8.30
Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet (2005) 4.82
Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med (2005) 4.72
Totally drug-resistant tuberculosis in India. Clin Infect Dis (2011) 4.31
Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect Dis (2011) 4.00
Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med (2006) 3.98
Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol (2011) 3.69
Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS (2002) 3.47
Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot. Am J Respir Crit Care Med (2006) 3.12
Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet (2004) 3.07
Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med (2013) 3.03
Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med (2008) 2.85
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J (2012) 2.61
Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study. Thorax (2011) 2.60
New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India (2010) 2.60
Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol (2007) 2.40
Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS (2005) 2.38
Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med (2008) 2.36
Successful management of highly drug resistant tuberculosis with individualised drug susceptibility testing. J Assoc Physicians India (2014) 2.34
International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008. Am J Infect Control (2008) 2.25
A comparison between two strategies for monitoring hepatic function during antituberculous therapy. Am J Respir Crit Care Med (2011) 2.22
Acid-fast bacilli culture positivity and drug resistance in abdominal tuberculosis in Mumbai, India. Indian J Gastroenterol (2014) 2.00
Increased risk of Mycobacterium tuberculosis infection in household child contacts exposed to passive tobacco smoke. Pediatr Infect Dis J (2014) 1.97
Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin Infect Dis (2004) 1.88
Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India. J Clin Microbiol (2010) 1.83
Evaluation of immigrant tuberculosis screening in industrialized countries. Emerg Infect Dis (2012) 1.81
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med (2004) 1.70
Retrospective study of interstitial lung disease in a tertiary care centre in India. Indian J Chest Dis Allied Sci (2011) 1.70
Ambulatory multi-drug resistant tuberculosis treatment outcomes in a cohort of HIV-infected patients in a slum setting in Mumbai, India. PLoS One (2011) 1.70
Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis (2004) 1.68
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. Am J Respir Crit Care Med (2011) 1.66
Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations. J Clin Microbiol (2013) 1.66
Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med (2005) 1.60
Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment? BMC Public Health (2010) 1.60
Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med (2005) 1.58
High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis (2005) 1.47
Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One (2010) 1.45
Potential yield of pulmonary tuberculosis cases by direct microscopy of sputum in a district of South India. Bull World Health Organ (1967) 1.40
Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (2011) 1.35
Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol (2004) 1.34
Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun (2004) 1.30
Are prolonged/continuous infusions of β-lactams for all? Clin Infect Dis (2013) 1.28
Tuberculosis and diabetes mellitus: merging epidemics. J Assoc Physicians India (2009) 1.28
Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states. PLoS One (2011) 1.24
Estimation of prevalence of bacillary tuberculosis on the basis of chest X-ray and/or symptomatic screening. Indian J Med Res (1976) 1.22
Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis. Thorax (2012) 1.21
Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection. Emerg Infect Dis (2013) 1.20
MDR, XDR, TDR tuberculosis: ominous progression. Thorax (2012) 1.19
XDR tuberculosis in India: what's in a name? Lancet Infect Dis (2007) 1.19
T-cell immunophenotyping distinguishes active from latent tuberculosis. J Infect Dis (2013) 1.18
Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One (2010) 1.18
Multidrug-resistant tuberculosis in Mumbai: it's only getting worse. Int J Tuberc Lung Dis (2006) 1.18
Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis (2003) 1.16
Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments. PLoS One (2012) 1.15
Ethnicity and mycobacterial lineage as determinants of tuberculosis disease phenotype. Thorax (2012) 1.14
Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study. J Clin Microbiol (2011) 1.12
Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients. Kidney Int (2004) 1.11
Rapid diagnosis of extensively drug-resistant tuberculosis by use of a reverse line blot hybridization assay. J Clin Microbiol (2011) 1.10
Antimycobacterial, antiprotozoal and cytotoxic potential of twenty-one brown algae (Phaeophyceae) from British and Irish waters. Phytother Res (2010) 1.08
Interferon gamma assays for tuberculosis. Lancet Infect Dis (2005) 1.08
The relevance of ESBL producing isolates in patients surgically treated for acute appendicitis. J Assoc Physicians India (2011) 1.08
A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest (2011) 1.07
Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India. J Clin Microbiol (2011) 1.06
Improved laboratory diagnosis of tuberculosis--the Indian experience. Tuberculosis (Edinb) (2011) 1.04
IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect (2010) 1.04
IGRAs--the gateway to T cell based TB diagnosis. Methods (2013) 1.02
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics (2007) 1.01
Salmonella typhiin the past decade: learning to live with resistance. Clin Infect Dis (2002) 1.00
BCG vaccination: 90 years on and still so much to learn ... Thorax (2010) 1.00
Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann Intern Med (2004) 0.99
Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden. Thorax (2010) 0.98
Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosis. J Infect Dis (2010) 0.98
Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now! Int J Antimicrob Agents (2010) 0.97
Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases. Indian J Med Res (2012) 0.96
Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression. PLoS One (2011) 0.96
Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts. Clin Infect Dis (2009) 0.94
Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults. Eur J Immunol (2012) 0.94
Disseminated tuberculosis with immune thrombocytopenic purpura. Lung India (2012) 0.93
Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study. BMJ Open (2012) 0.93
Osteoarticular tuberculosis--diagnostic solutions in a disease endemic region. J Infect Dev Ctries (2009) 0.92
Tuberculosis in India. BMJ (2015) 0.92
Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb) (2012) 0.92